NSC |
Compound |
Enrichment |
Correlation |
NSC 719661 |
1-O-Octadecyl-[(2.fwdarw.5')-3'-C-ethinyl-cytidylyl]-rac-glycerylyl-(3.fwdarw.5')-5-fluoro-2'-deoxyuridine |
0.0139289274573436 |
-0.015722523 |
NSC 720715 |
Null |
0.0139289274573436 |
-0.020314975 |
NSC 743221 |
N3-(4-chloro-3-methylphenyl)-N2-(4-fluorophenyl)-5-oxo-7-pro pyl-5H-[1,3]thiazolo[3,2-a]pyrimidine-2,3-dicarboxamide |
0.0139289274573436 |
0.16981686 |
NSC 749076 |
3-(7-methoxy-3-methyl-1,4-dioxy-quinoxalin-2-yl)-1-(3,4,5-trimethoxy-phenyl)-propenone |
0.0139289274573436 |
0.27674629 |
NSC 95170 |
Null |
0.0139289274573436 |
0.15753161 |
NSC 146604 |
FUR |
0.0145667015252499 |
0.0067796104 |
NSC 402717 |
Null |
0.0145667015252499 |
0.19498662 |
NSC 606698 |
Rapamycin prodrug, Mono-(28)-N,N-dimethylglycinate-, methanesulfonic acid salt |
0.0145667015252499 |
0.0092510622 |
NSC 617965 |
Null |
0.01456670152525 |
-0.19005111 |
NSC 633781 |
1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate |
0.01456670152525 |
0.083490038 |